AC-73 and Syrosingopine Inhibit SARS-CoV-2 Entry into Megakaryocytes by Targeting CD147 and MCT4

AC-73 and Syrosingopine Inhibit SARS-CoV-2 Entry into Megakaryocytes by Targeting CD147 and MCT4

Coagulation disorders are described in COVID-19 and long COVID patients. In particular, SARS-CoV-2 infection in megakaryocytes, which are precursors of platelets involved in thrombotic events in COVID-19, long COVID and, in rare cases, in vaccinated individuals, requires further investigation, parti...

Full description

Bibliographic Details
Main Authors: Isabella Spinello, Ernestina Saulle, Maria Teresa Quaranta, Elvira Pelosi, Germana Castelli, Annamaria Cerio, Luca Pasquini, Ornella Morsilli, Maria Luisa Dupuis, Catherine Labbaye
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Viruses
Subjects:
SARS-CoV-2
coagulation disorders
megakaryocytes
CD147
MCT4
Online Access:https://www.mdpi.com/1999-4915/16/1/82

Similar Items

Similar Items